High RAC3 expression levels are required for induction and maintaining of cancer cell stemness

RAC3 is a transcription coactivator, usually overexpressed in several tumors and required to maintain the pluripotency in normal stem cells. In this work we studied the association between RAC3 overexpression on cancer cell stemness and the capacity of this protein to induce cancer stem properties in non tumoral cells. We performed in vitro and in vivo experiments using two strategies: by overexpressing RAC3 in the non tumoral cell line HEK293 and by silencing RAC3 in the human colorectal epithelial cell line HCT116 by transfection. Furthermore, we analysed public repository microarrays data from human colorectal tumors in different developmental stages. We found that RAC3 overexpression was mainly associated to CD133+ side-population of colon cancer cells and also to early and advanced stages of colon cancer, involving increased expression of mesenchymal and stem markers. In turn, RAC3 silencing induced diminished tumoral properties and cancer stem cells as determined by Hoechst efflux, tumorspheres and clonogenic growth, which correlated with decreased Nanog and OCT4 expression. In non tumoral cells, RAC3 overexpression induced tumoral transformation; mesenchymal phenotype and stem markers expression. Moreover, these transformed cells generated tumors in vivo. Our results demonstrate that RAC3 is required for maintaining and induction of cancer cell stemness.

• Publication year

  2017

• Venue

  OncoTarget

• Publication date

  2017-12-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.18632/oncotarget.23635PMID 29464039PMCID 5814179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells

  2017cited by this paper
• PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy

  2016cited by this paper
• Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid

  2015cited by this paper
• Stem cells are units of natural selection for tissue formation, for germline development, and in cancer development

  2015cited by this paper
• RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging

  2015cited by this paper
• The levels of RAC3 expression are up regulated by TNF in the inflammatory response

  2014cited by this paper
• Critical Components of the Pluripotency Network Are Targets for the p300/CBP Interacting Protein (p/CIP) in Embryonic Stem Cells

  2014cited by this paper
• Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells

  2014cited by this paper
• Signaling mechanisms of the epithelial-mesenchymal transition

  2014cited by this paper
• CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches

  2013influential reference
• Essential roles for the nuclear receptor coactivator Ncoa3 in pluripotency

  2013cited by this paper
• AIB1 Cooperates with ERα to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation

  2013cited by this paper
• CD133: a stem cell biomarker and beyond

  2013influential reference
• Genetic and epigenetic variations in iPSCs: potential causes and implications for application.

  2013cited by this paper
• Nuclear receptor coactivator RAC3 inhibits autophagy

  2012cited by this paper
• Role of Nuclear Receptor Coactivator 3 (Ncoa3) in Pluripotency Maintenance*

  2012cited by this paper
• Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming.

  2012cited by this paper
• Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition

  2012cited by this paper
• Understanding cancer stem cell heterogeneity and plasticity

  2012cited by this paper
• Cyclin D1 is a NF-κB corepressor.

  2012cited by this paper
• SRC-3 Has a Role in Cancer Other Than as a Nuclear Receptor Coactivator

  2011cited by this paper
• SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration.

  2010cited by this paper
• Characterization of a Cancer Stem Cell-Like Side Population Derived from Human Pancreatic Adenocarcinoma Cells

  2010cited by this paper
• A PAK-activated linker for EGFR and FAK.

  2010cited by this paper
• Heterogeneity in cancer: cancer stem cells versus clonal evolution.

  2009cited by this paper
• The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action

  2008cited by this paper
• The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression

  2008cited by this paper
• RAC3 down‐regulation sensitizes human chronic myeloid leukemia cells to TRAIL‐induced apoptosis

  2007cited by this paper
• Cancer Stem Cells

  2007cited by this paper
• GENERATION OF GERMLINECOMPETENT INDUCED PLURIPOTENT STEM CELLS

  2007influential reference
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Cancer initiation and progression: involvement of stem cells and the microenvironment.

  2007cited by this paper
• SRC-3/AIB1: transcriptional coactivator in oncogenesis

  2006cited by this paper
• Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

  2006cited by this paper
• Cancer stem cells.

  2005cited by this paper
• NF-kappaB: linking inflammation and immunity to cancer development and progression.

  2005cited by this paper
• Atypical protein kinase C‐ζ modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells

  2005cited by this paper
• SRC-3 is required for prostate cancer cell proliferation and survival.

  2005cited by this paper
• High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.

  2004cited by this paper
• Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma

  2004cited by this paper
• High-throughput microtiter assay for Hoechst 33342 dye uptake

  2004cited by this paper
• Tissue repair and stem cell renewal in carcinogenesis

  2004cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• RAC-3 is a NF-kappa B coactivator.

  2000cited by this paper
• RAC‐3 is a NF‐κB coactivator

  2000cited by this paper
• Amplification and over‐expression of the AIB1 nuclear receptor co‐activator gene in primary gastric cancers

  2000cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.

  1997cited by this paper

• Constructing Cell-Specific Causal Networks of Individual Cells for Depicting Dynamical Biological Processes

  2025cites this paper
• Prion-induced ferroptosis is facilitated by RAC3

  2025cites this paper
• Tumor-secreted TNF induces NCoA3 upregulation in breast cancer-associated adipocytes via TNFR1/NF-κB signaling.

  2025cites this paper
• Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target

  2023cites this paper
• Functional relationship between CFTR and RAC3 expression for maintaining cancer cell stemness in human colorectal cancer

  2021cites this paper
• Bioinformatic identification of prognostic indicators in bladder cancer.

  2020cites this paper
• Extract from Aloysia polystachya Induces the Cell Death of Colorectal Cancer Stem Cells

  2020cites this paper
• The inflammatory cytokine TNF contributes with RAC3-induced malignant transformation

  2018cites this paper